help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 3, 2009, doi:10.1164/rccm.200904-0552OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200904-0552OCv1
180/12/1179    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Freeman, C. M.
Right arrow Articles by Curtis, J. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeman, C. M.
Right arrow Articles by Curtis, J. L.
American Journal of Respiratory and Critical Care Medicine Vol 180. pp. 1179-1188, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200904-0552OC


Original Article

Lung Dendritic Cell Expression of Maturation Molecules Increases with Worsening Chronic Obstructive Pulmonary Disease

Christine M. Freeman1, Fernando J. Martinez2, MeiLan K. Han2, Theresa M. Ames2, Stephen W. Chensue3,4,5, Jill C. Todt2, Douglas A. Arenberg2, Catherine A. Meldrum2, Christi Getty2, Lisa McCloskey2 and Jeffrey L. Curtis1,2,5

1 Pulmonary and Critical Care Medicine Section, VA Ann Arbor Healthcare System, Ann Arbor; 2 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor; 3 Pathology & Laboratory Medicine Service, VA Ann Arbor Healthcare System, Ann Arbor; and 4 Department of Pathology and 5 Graduate Program in Immunology, University of Michigan Health System, Ann Arbor, Michigan

Correspondence and requests for reprints should be addressed to Jeffrey L. Curtis, M.D., Pulmonary and Critical Care Medicine Section (506/111G), Department of Veterans Affairs Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105-2303. E-mail: jlcurtis{at}umich.edu

Rationale: Dendritic cells (DCs) have not been well studied in chronic obstructive pulmonary disease (COPD), yet their integral role in activating and differentiating T cells makes them potential participants in COPD pathogenesis.

Objectives: To determine the expression of maturation molecules by individual DC subsets in relationship to COPD stage and to expression of the acute activation marker CD69 by lung CD4+ T cells.

Methods: We nonenzymatically released lung leukocytes from human surgical specimens (n = 42) and used flow cytometry to identify three DC subsets (mDC1, mDC2, and pDC) and to measure their expression of three costimulatory molecules (CD40, CD80 and CD86) and of CD83, the definitive marker of DC maturation. Spearman nonparametric correlation analysis was used to identify significant correlations between expression of DC maturation molecules and COPD severity.

Measurements and Main Results: Expression of CD40 by mDC1 and mDC2 and of CD86 by mDC2 was high regardless of GOLD stage, but CD80 and CD83 on these two DC subsets increased with disease progression. pDC also showed significant increases in expression of CD40 and CD80. Expression of all but one of the DC molecules that increased with COPD severity also correlated with CD69 expression on lung CD4+ T cells from the same patients, with the exception of CD83 on mDC2.

Conclusions: This cross-sectional study implies that COPD progression is associated with significant increases in costimulatory molecule expression by multiple lung DC subsets. Interactions with lung DCs may contribute to the immunophenotype of CD4+ T cells in advanced COPD.

Clinical trial registered with www.clinicaltrials.gov (NCT00281229).

Key Words: human • flow cytometry • B70 costimulatory molecules • CD69 antigen • CD4+ • T lymphocytes


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Dendritic cells (DCs) are necessary to activate and induce differentiation of naive and effector T cells in response to antigens. However, the few studies that have addressed the involvement of lung DCs in chronic obstructive pulmonary disease (COPD) have found conflicting answers and have not examined maturational state as a function of disease stage.

What This Study Adds to the Field
DC subsets from human lungs showed increased costimulatory molecule expression that correlated with COPD severity and was not explained by smoking alone. Lung DCs colocalized with CD4+ T cells, and expression of DC activation markers correlated with expression of CD69, an early and transient marker of T-cell activation, on CD4+ T cells from the same patients.

 

Related articles in AJRCCM:

Smoking Gun: Mature Dendritic Cells in Human Lung Provide Clues to Chronic Obstructive Pulmonary Disease
Farrah Kheradmand, Ming Shan, and David B. Corry
AJRCCM 2009 180: 1166-1167. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Kheradmand, M. Shan, and D. B. Corry
Smoking Gun: Mature Dendritic Cells in Human Lung Provide Clues to Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 15, 2009; 180(12): 1166 - 1167.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  Registrer for the conference